We are live on ! Find out more
JNJ icon

Johnson & Johnson

3,680 hedge funds and large institutions have $260B invested in Johnson & Johnson in 2023 Q3 according to their latest regulatory filings, with 151 funds opening new positions, 1,220 increasing their positions, 2,000 reducing their positions, and 181 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more call options, than puts

Call options by funds: $3.26B | Put options by funds: $2.81B

0.63% less ownership

Funds ownership: 69.83%69.2% (-0.63%)

2% less funds holding

Funds holding: 3,7533,680 (-73)

13% less capital invested

Capital invested by funds: $300B → $260B (-$40B)

17% less first-time investments, than exits

New positions opened: 151 | Existing positions closed: 181

19% less funds holding in top 10

Funds holding in top 10: 457370 (-87)

39% less repeat investments, than reductions

Existing positions increased: 1,220 | Existing positions reduced: 2,000

Holders
3,680
Holders Change
-73
Holders Change %
-1.95%
% of All Funds
58.38%
Holding in Top 10
370
Holding in Top 10 Change
-87
Holding in Top 10 Change %
-19.04%
% of All Funds
5.87%
New
151
Increased
1,220
Reduced
2,000
Closed
181
Calls
$3.26B
Puts
$2.81B
Net Calls
+$450M
Net Calls Change
-$1.15B
Name Holding Trade Value Shares
Change
Change in
Stake
PFS
1401
Physicians Financial Services
North Carolina
$4.39M -$4.95K -30 -0.1%
KFI
1402
Key Financial Inc
Pennsylvania
$4.39M +$3.3K +20 +0.1%
SL
1403
Summitry LLC
California
$4.39M +$170K +1,031 +4%
SP
1404
Symmetry Partners
Connecticut
$4.34M +$205K +1,244 +5%
MMHP
1405
Murphy Middleton Hinkle & Parker
Georgia
$4.32M +$33.2K +201 +0.7%
MSA
1406
Marino Stram & Associates
Massachusetts
$4.32M -$1.5M -9,087 -25%
MCCP
1407
Mission Creek Capital Partners
California
$4.32M -$495 -3 -0%
DA
1408
Dillon & Associates
Michigan
$4.31M -$57.8K -350 -1%
JWCA
1409
J.W. Coons Advisors
Ohio
$4.3M -$312K -1,889 -6%
HP
1410
Hyperion Partners
Pennsylvania
$4.3M +$495 +3 +0%
LC
1411
Lincoln Capital
Nebraska
$4.29M +$1.81K +11 +0%
WEG
1412
World Equity Group
Illinois
$4.29M +$2.1M +12,717 +86%
SRC
1413
Shufro Rose & Co
New York
$4.26M -$82.5K -500 -2%
EB
1414
Exchange Bank
California
$4.26M -$133K -805 -3%
FIA
1415
Foundations Investment Advisors
Arizona
$4.26M -$270K -1,637 -6%
Loomis, Sayles & Company
1416
Loomis, Sayles & Company
Massachusetts
$4.24M -$386K -2,337 -8%
PAM
1417
Pegasus Asset Management
New York
$4.24M +$60.7K +368 +1%
OCAM
1418
Onex Canada Asset Management
Ontario, Canada
$4.24M -$598K -3,626 -12%
KA
1419
Kovack Advisors
Florida
$4.21M +$457K +2,772 +11%
AAS
1420
Ameritas Advisory Services
Nebraska
$4.2M +$1.93M +11,695 +75%
CFSG
1421
Community Financial Services Group
Vermont
$4.19M +$4.44M +26,918 New
FMTC
1422
Farmers & Merchants Trust Company
California
$4.19M -$163K -986 -4%
Aristotle Capital Management
1423
Aristotle Capital Management
California
$4.19M
MMA
1424
Miracle Mile Advisors
California
$4.19M -$305K -1,847 -6%
BEC
1425
Blue Edge Capital
Virginia
$4.18M +$5.12K +31 +0.1%

JNJ Hedge Fund Activity: Q3 2023 in Review

3,680 of the 6,303 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q3 2023, worth a combined $260B — down 13% from $300B a quarter earlier.

Sellers outnumbered buyers: 181 funds closed out of JNJ and 151 opened new positions — a net loss of 30 holders — while 2,000 trimmed existing stakes and 1,220 added.

The largest buyer was Goldman Sachs, adding an estimated $394M. The largest seller was Vanguard Group, cutting an estimated $3B.

  • 3,680 institutional investors held Johnson & Johnson (JNJ) as of Q3 2023, down from 3,753 in Q2 2023.
  • Funds reported $260B of Johnson & Johnson stock for Q3 2023, down 13% quarter-over-quarter.
  • 151 funds opened new Johnson & Johnson positions in Q3 2023 and 181 closed out, a net change of -30 holders.
  • The largest Johnson & Johnson buyer in Q3 2023 was Goldman Sachs, an estimated $394M added.
  • The largest Johnson & Johnson seller in Q3 2023 was Vanguard Group, an estimated $3B sold.

Based on aggregated 13F filings for Q3 2023.